Epinephrine now
- Give IM epinephrine 0.3–0.5 mg in the anterolateral thigh
- Repeat every 5–15 minutes if airway, breathing or circulatory compromise persists
- Call for help, position supine when tolerated and give oxygen
Airway, bronchospastic or circulatory collapse not responding to initial anaphylaxis therapy.
Anaphylaxis: epinephrine first, airway early, escalate refractory shock
IM epinephrine is first-line treatment. Antihistamines and steroids are adjuncts, not substitutes, and should never delay epinephrine.
Recognize anaphylaxis clinically; skin findings may be absent. Do not wait for tryptase.
Give repeated IM epinephrine, oxygen and crystalloid; secure an early expert airway if edema progresses. For persistent shock, use a monitored titrated IV epinephrine infusion.
Reassess airway edema, bronchospasm, perfusion and epinephrine response; treat biphasic-risk patients with appropriate monitored observation.
Evidence status
Review metadata not yet recorded.
Status, review dates and guideline versions appear here once editorial metadata is authored for this content.
From identifying weaning failure pathophysiology to progressive conditioning, tracheostomy timing (days 7–14), and speaking valve decannulation.
From recognizing hypoperfusion and initial crystalloid bolus to dynamic fluid responsiveness assessment and vasopressor targets.
From first-line norepinephrine titration to multi-agent vasopressor escalation and inotrope selection.
From multi-vasopressor failure to rescue non-adrenergic agents and mechanical circulatory support.
Immediate epinephrine-first management of airway edema, bronchospasm, vasoplegia and refractory anaphylactic shock in the ICU.
Cellular dysoxia, DO2/VO2 physiology, the 4 shock phenotypes, dynamic fluid responsiveness (PLR/PPV) vs fluid tolerance (VExUS), and vasoactive pharmacology.
The 7 Ps of ICU intubation, the physiologically difficult airway, BOUGIE/DEVICE video laryngoscopy trials, hemodynamic optimization, waveform capnography, and scalpel-bougie cricothyroidotomy.